Background illustration for clinical trials search

Paid Clinical Trials Greensboro

Discover 1,825 paid clinical trials in Greensboro, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subjects With One Level, Symptomatic Mild to Moderate Lumbar Degenerative Disc Disease

for
Degenerative Disc Disease
Location: Winston-Salem NC, Richmond VA, Wilmington NC,
Sponsor: DiscGenics, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07254806

Phase 3, Recruiting
Active & Responsive

ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)

for
Autosomal Dominant Polycystic Kidney Disease
Location: Winston-Salem NC, Chapel Hill NC, Knoxville TN,
Sponsor: Calico Life Sciences LLC

Sex: All

Age: 18 - 55

Code: NCT06902558

Phase 2, Recruiting
Active & Responsive

A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)

for
Lumbar Disc Disease
Location: Winston-Salem NC, Richmond VA, Cleveland OH,
Sponsor: BioRestorative Therapies

Sex: All

Age: 18+

Code: NCT04042844

Phase 2, Recruiting
Active & Responsive

A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)

for
Relapsed Refractory Multiple Myeloma
Location: Winston-Salem NC, Charlotte NC, Atlanta GA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07391657

Phase 3, Recruiting
Active & Responsive

A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy

for
Kidney Disease
Location: Winston-Salem NC, Arlington VA, Morgantown WV,
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT06963827

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & ResponsiveNew

A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-005)

for
Diabetic Retinopathy, Macular Edema
Location: Winston-Salem NC, Hickory NC, Greenville NC, Aiken SC,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07705607

Phase 3, Recruiting
Active & ResponsiveNew

Study to Evaluate Safety of C-1101 Versus Sterile Saline in Adults With Chronic Painful Lumbosacral Radiculopathy

for
Lumbosacral Radicular Pain, Sciatic Radiculopathy,
Location: Winston-Salem NC, Fernandina Beach FL
Sponsor: Consano Bio

Sex: All

Age: 18 - 70

Code: NCT07264270

Phase 1, Recruiting
Active & Responsive

A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy

for
Spinal Muscular Atrophy (SMA)
Location: Hillsborough NC, New York NY, Hartford CT, Kissimmee FL,
Sponsor: argenx

Sex: All

Age: 5 - 17

Code: NCT07287982

Phase 2, Recruiting
Active & Responsive

Tafasitamab and Rituximab for Front-Line Treatment of Post-Transplant Lymphoproliferative Disorder

for
Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder,
Location: Hillsborough NC, Columbus OH, New Brunswick NJ,
Sponsor: Timothy Voorhees

Sex: All

Age: 18+

Code: NCT05786040

Phase 2, Recruiting
Active & Responsive

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

for
NASH With Fibrosis, MASH With Fibrosis
Location: Chapel Hill NC, Durham NC, Raleigh NC, Statesville NC,
Sponsor: Akero Therapeutics, Inc

Sex: All

Age: 18 - 70+

Code: NCT06215716

Phase 3, Recruiting
Active & Responsive

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

for
NASH - Nonalcoholic Steatohepatitis,
Location: Chapel Hill NC, Durham NC, Raleigh NC, Statesville NC,
Sponsor: Akero Therapeutics, Inc

Sex: All

Age: 18 - 70+

Code: NCT06528314

Phase 3, Recruiting
Active & Responsive

Daily Upgrade Trial

for
Healthy Women
Location: Chapel Hill NC
Sponsor: University of North Carolina, Chapel Hill

Sex: Female

Age: 25 - 45

Code: NCT07792603

Recruiting
Active & Responsive

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

for
Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma
Location: Chapel Hill NC, Durham NC, Raleigh NC, Clinton NC,
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT07198074

Phase 3, Recruiting
Active & Responsive

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

for
Metastatic Head and Neck Squamous Cell Carcinoma,
Location: Chapel Hill NC, Pinehurst NC, Hendersonville NC,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06589804

Phase 3, Recruiting
Active & Responsive

A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment

for
Lung Non-Small Cell Carcinoma
Location: Chapel Hill NC, Washington PA, Greensburg PA,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT07293247

Phase 2, Recruiting
Active & Responsive

A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

for
Non-small Cell Lung Cancer
Location: Chapel Hill NC, Raleigh NC, Asheville NC,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07513376

Phase 3, Recruiting
Active & Responsive

PREDICT-RD: ctDNA Surveillance in TNBC With Residual Disease

for
Breast Cancer, Residual Disease,
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT07069595

Phase 2, Recruiting
Active & Responsive

Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma

for
Pleuropulmonary Blastoma
Location: Chapel Hill NC, Durham NC, Charlottesville VA,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 21

Code: NCT06647953

Phase 3, Recruiting
Active & Responsive

CARED : A Novel Rapid Treatment Paradigm for Depression

for
Major Depressive Disorder
Location: Chapel Hill NC
Sponsor: University of North Carolina, Chapel Hill

Sex: All

Age: 18 - 70

Code: NCT07507370

Recruiting
Active & Responsive

Modulation of Brain Rhythms in Stroke

for
Stroke
Location: Chapel Hill NC
Sponsor: University of North Carolina, Chapel Hill

Sex: All

Age: 45 - 70+

Code: NCT07121582

Recruiting